Post marketing prospective study of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infectio
Not Applicable
- Conditions
- hepatitis C virus infection
- Registration Number
- JPRN-UMIN000023267
- Lead Sponsor
- Second department of internal mediceine, Wakayama medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)pregnant woman 2)decompensated cirrhosis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained virological response at 12 weeks after treatment
- Secondary Outcome Measures
Name Time Method